Aditxt, Inc. Proceeds from Notes Payable
Aditxt, Inc. (ADTX) reported Proceeds from Notes Payable of $451.97 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-03-31
- Aditxt, Inc. proceeds from notes payable for the quarter ending 2024-06-30 was $0.00.
- Aditxt, Inc. proceeds from notes payable for the quarter ending 2024-03-31 was $451.97K.
- Aditxt, Inc. proceeds from notes payable for the quarter ending 2022-09-30 was $2.59M.
- Aditxt, Inc. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00.
- Aditxt, Inc. proceeds from notes payable for fiscal 2021 was $5.00M, a 1233.33% increase from fiscal 2020.
- Aditxt, Inc. proceeds from notes payable for fiscal 2020 was $375.00K, a 650.00% increase from fiscal 2019.
- Aditxt, Inc. proceeds from notes payable for fiscal 2019 was $50.00K.
| Period end | Proceeds from Notes Payable | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $451.97K 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | $451.97K 10-Q · filed 2024-05-20 | ||||
| 2023-10-05 | $3.00M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.14M 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $550.00K 10-Q · filed 2022-08-15 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 derived: sum of 3 quarters · filed 2022-11-14 | $5.00M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $5.00M 10-Q · filed 2022-11-14 | $5.00M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.00M 10-Q · filed 2022-08-15 | $5.00M derived: sum of 3 quarters · filed 2022-08-15 | $5.00M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-16 | $5.00M derived: sum of 2 quarters · filed 2022-05-16 | $5.00M derived: sum of 3 quarters · filed 2022-05-16 | $5.04M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $40.00K derived: sum of 3 quarters · filed 2022-03-31 | $375.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $40.00K derived: sum of 2 quarters · filed 2021-11-15 | $375.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $375.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $335.00K 10-Q · filed 2021-05-12 | ||||
| 2019-12-31 | $50.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |